A scoping review of the use of cannabidiol in psychiatric disorders.
Kirkland AE, Fadus MC, Gruber SA, Gray KM, Wilens TE, Squeglia LM.
Psychiatry Res. 2022 Feb;308:114347. doi: 10.1016/j.psychres.2021.114347. Epub 2021 Dec 20.
Prevention of Psychosis: Advances in Detection, Prognosis, and Intervention.
Fusar-Poli P, Salazar de Pablo G, Correll CU, Meyer-Lindenberg A, Millan MJ, Borgwardt S, Galderisi S, Bechdolf A, Pfennig A, Kessing LV, van Amelsvoort T, Nieman DH, Domschke K, Krebs MO, Koutsouleris N, McGuire P, Do KQ, Arango C.
JAMA Psychiatry. 2020 Jul 1;77(7):755-765. doi: 10.1001/jamapsychiatry.2019.4779.
Psychedelics: Alternative and Potential Therapeutic Options for Treating Mood and Anxiety Disorders.
Lowe H, Toyang N, Steele B, Grant J, Ali A, Gordon L, Ngwa W.
Molecules. 2022 Apr 14;27(8):2520. doi: 10.3390/molecules27082520.
Risk and protective factors for mental disorders beyond genetics: an evidence-based atlas.
Arango C, Dragioti E, Solmi M, Cortese S, Domschke K, Murray RM, Jones PB, Uher R, Carvalho AF, Reichenberg A, Shin JI, Andreassen OA, Correll CU, Fusar-Poli P.
World Psychiatry. 2021 Oct;20(3):417-436. doi: 10.1002/wps.20894.
Associations of alcohol and tobacco use with psychotic, depressive and developmental disorders revealed via multimodal neuroimaging.
Qiu L, Liang C, Kochunov P, Hutchison KE, Sui J, Jiang R, Zhi D, Vergara VM, Yang X, Zhang D, Fu Z, Bustillo JR, Qi S, Calhoun VD.
Transl Psychiatry. 2024 Aug 7;14(1):326. doi: 10.1038/s41398-024-03035-2.
Effect of the GLP-1 receptor agonist semaglutide on metabolic disturbances in clozapine-treated or olanzapine-treated patients with a schizophrenia spectrum disorder: study protocol of a placebo-controlled, randomised clinical trial (SemaPsychiatry).
Sass MR, Danielsen AA, Köhler-Forsberg O, Storgaard H, Knop FK, Nielsen MØ, Sjödin AM, Mors O, Correll CU, Ekstrøm C, Vinberg M, Nielsen J, Vilsbøll T, Fink-Jensen A.
BMJ Open. 2023 Jan 31;13(1):e068652. doi: 10.1136/bmjopen-2022-068652.
Psychedelics as a potential treatment for tobacco use disorder: a systematic review.
Spoelstra SK, Schoevers RA, Venema SD, Knegtering H.
Discov Ment Health. 2024 Sep 17;4(1):37. doi: 10.1007/s44192-024-00095-0.
Mediating Effect of Perceived Stress on the Association between Physical Activity and Sleep Quality among Chinese College Students.
Zhai X, Wu N, Koriyama S, Wang C, Shi M, Huang T, Wang K, Sawada SS, Fan X.
Int J Environ Res Public Health. 2021 Jan 2;18(1):289. doi: 10.3390/ijerph18010289.
Use of tobacco in schizophrenia: A double-edged sword.
Fang Y, Wang W, Zhu C, Lin GN, Cheng Y, Zou J, Cui D.
Brain Behav. 2019 Nov;9(11):e01433. doi: 10.1002/brb3.1433. Epub 2019 Oct 11.
Using Mismatch Negativity to Investigate the Pathophysiology of Substance Use Disorders and Comorbid Psychosis.
Ramlakhan JU, Zomorrodi R, Downar J, Blumberger DM, Daskalakis ZJ, George TP, Kiang M, Barr MS.
Clin EEG Neurosci. 2018 Jul;49(4):226-237. doi: 10.1177/1550059418760077. Epub 2018 Mar 4.
